This research aims to evaluate the effectiveness of expectant management versus medication for managing patent ductus arteriosus in preterm infants.
Performed a randomized clinical trial comparing two treatment strategies.
Focused on preterm infants diagnosed with patent ductus arteriosus.
Utilized a critical appraisal approach to summarize findings.
The trial findings will guide treatment choices for patent ductus arteriosus in a vulnerable population of preterm infants.
Resumen
Critically Appraised Summary Table (CAST) for the "Expectant Management vs Medication for Patent Ductus Arteriosus in Preterm Infants: The PDA Randomized Clinical Trial."